Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees

Journal of Virology

Volumn 74, Issue 19, 2000, Pages 9317-9321

  Teng, M N ^a   Whitehead, S S ^a   Bermingham, A ^a   St Claire, M ^a   Elkins, W R ^a   Murphy, B R ^a   Collins, P L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; PROTEIN; PROTEIN M2 2; PROTEIN NS1; RESPIRATORY SYNCYTIAL VIRUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMPANZEE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; GENETIC STABILITY; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIROGENESIS; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMAL; ANTIGENS, VIRAL; MUTATION; PAN TROGLODYTES; RECOMBINATION, GENETIC; RESPIRATORY SYNCYTIAL VIRUSES; SUPPORT, U.S. GOV'T, P.H.S.; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS;

EID: 0033803734     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.19.9317-9321.2000     Document Type: Article

References (34)

1. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription
2. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter
3. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): Effects on host range and evaluation as a live-attenuated HRSV vaccine
4. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse
5. Production of infectious human respiratory syncytial virus from cloned eDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development
6. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus
7. Respiratory syncytial virus
8. Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics
9. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes
10. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization
11. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees
12. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis
13. The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation
14. Respiratory syncytial virus vaccines
15. Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate
16. Low-temperature-grown RS virus in adult volunteers
17. Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults
18. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA
19. The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription
20. Respiratory syncytial virus that lacks open reading frame 2 of the M2 gene (M2-2) has altered growth characteristics and is attenuated in rodents
21. The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein
22. The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis
23. Respiratory syncytial virus infection in the elderly
24. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines
25. Bronchiolitis-associated hospitalizations among US children 1980-1996
26. Altered growth characteristics of recombinant respiratory syncytial viruses which do not produce NS2 protein
27. Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV
28. Respiratory syncytial virus and para-influenza virus infections in the immunocompromised host
29. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees
30. A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes
31. Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidates
32. Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees
33. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus (RSV) vaccine candidate in infancy
34. Functional cDNA clones of the human respiratory syncytial (RS) virus N, P, and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication